FELISHA MILLER: Open Payments
NPI 1588061048 · COOS BAY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 31 payments from 21 companies in 2025. Trend: 2023 $175 · 2024 $1,239 · 2025 $920
Food & beverage: $721Education: $199
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $100 |
| SEAGEN INC. | 1 | $99 |
| ABBVIE INC. | 4 | $85 |
| Incyte Corporation | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 2 | $65 |
| TerSera Therapeutics LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Stemline Therapeutics Inc. | 1 | $35 |
| Exelixis Inc. | 1 | $33 |
Products named: FOTIVDA, OPDIVO, EPKINLY, JAKAFI, Quzyttir, LIBTAYO, JEMPERLI, IMBRUVICA.
Industry payments across OR — which companies pay providers there.
